Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 5/20 | 0.74 |
| ▸ | CTSK | P43235 | 4/20 | 0.74 |
| ▸ | CTSB | P07858 | 3/20 | 0.74 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.69 |
| ▸ | ACE | P12821 | 5/20 | 0.64 |
| ▸ | MME | P08473 | 4/20 | 0.58 |
| ▸ | CPA1 | P15085 | 2/20 | 0.58 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.58 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.57 |
| ▸ | PPARA | Q07869 | 5/20 | 0.56 |
| ▸ | PPARG | P37231 | 4/20 | 0.56 |
| ▸ | CTSL | P07711 | 1/20 | 0.54 |
| ▸ | PPARD | Q03181 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29397962 | 1.00 | CTSS (0.74) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL1519727 | 1.00 | CTSS (0.74) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL3821361 | 1.00 | CTSS (0.74) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL1519731 | 1.00 | CTSS (0.74) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL29436862 | 1.00 | CTSS (0.74) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL29401906 | 1.00 | CTSS (0.74) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL11025727 | 0.96 | CTSS (0.69) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL8660381 | 0.96 | CTSS (0.69) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL23016701 | 0.91 | CTSS (0.62) | CTSSCTSKCTSBPTPN1ACE | |
| SCHEMBL17817170 | 0.91 | CTSS (0.62) | CTSSCTSKCTSBPTPN1ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| WO-2025106939-A1 | CONJUGATES TARGETING FIBROBLAST ACTIVATION PROTEIN AND USES THEREOF | Praxis Biotech LLC (US) | 2025-05-22 | — | — | WO | disclosed |
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023199881-A1 | METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE AND RESIST UNDERLAYER FILM FORMING COMPOSITION | JSR株式会社 | 2023-10-19 | — | — | WO | disclosed |
| CN-111562720-B | Photo-sensitized chemically amplified resist material, pattern forming method, semiconductor device, mask for lithography, and template for nanoimprint | 东京毅力科创株式会社 | 2023-09-29 | — | — | CN | disclosed |
| CN-116082435-A | Dipeptide and tripeptide immunoproteasome inhibitor and preparation method and pharmaceutical application thereof | 中国医学科学院药物研究所 | 2023-05-09 | — | — | CN | disclosed |
| WO-2022259885-A1 | SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD AND COMPOSITION FOR FORMING RESIST UNDERLAYER FILM | JSR株式会社 | 2022-12-15 | — | — | WO | disclosed |
| WO-2022244682-A1 | SEMICONDUCTOR SUBSTRATE MANUFACTURING METHOD, AND RESIST BASE FILM FORMING COMPOSITION | JSR株式会社 | 2022-11-24 | — | — | WO | disclosed |
| EP-4017586-A1 | ENZYME INHIBITORS | Kalvista Pharmaceuticals Limited (GB) | 2022-06-29 | — | — | EP | disclosed |
| CN-114269431-A | Enzyme inhibitors | 卡尔维斯塔制药有限公司 | 2022-04-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | CTSS 4022/4885CTSK 4661/4885CTSB 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.